317 related articles for article (PubMed ID: 2864903)
1. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
[TBL] [Abstract][Full Text] [Related]
2. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
4. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
[TBL] [Abstract][Full Text] [Related]
6. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
Pagani F; Zecca M; Giachetti A
Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):349-51. PubMed ID: 2891046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats.
Impicciatore M; Chiavarini M; Morini G; Barocelli E; Molina E; Plazzi PV
Agents Actions; 1985 Sep; 16(6):496-500. PubMed ID: 2866688
[TBL] [Abstract][Full Text] [Related]
9. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
Weingart J; Kunert H; Ottenjann R
Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.
Lavezzo A; Manzoni L; Bianchetti A; Manara L
J Pharm Pharmacol; 1986 Nov; 38(11):853-6. PubMed ID: 2879021
[TBL] [Abstract][Full Text] [Related]
13. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
14. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
16. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
Domschke W; Lux G; Domschke S
Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
18. Famotidine and ranitidine: any difference in the duration of action?
Coruzzi G; Bertaccini G
Pharmacol Res Commun; 1987 Jan; 19(1):15-27. PubMed ID: 2883670
[TBL] [Abstract][Full Text] [Related]
19. Effect of mifentidine on mepirizole-induced duodenal ulcer in the rat.
Brambilla A; Ghiorzi A; De Paoli AM; Giachetti A
Pharmacol Res Commun; 1987 Dec; 19(12):877-85. PubMed ID: 2896364
[TBL] [Abstract][Full Text] [Related]
20. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
